Bing Xu is a Research Scientist at the Masonic Medical Research Institute (MMRI) since July 2018, focusing on the role of macrophage RhoA signaling in cardiac repair and remodeling. Prior to this, Bing Xu has been a Postdoctoral Research Scientist at Cedar Sinai Medical Center since February 2014, investigating the regulation and remodeling of BIN1-induced membrane microdomains in cardiomyocytes during heart failure progression. Bing Xu holds a Ph.D. in Molecular Biology from China Agricultural University, obtained between 1998 and 2001.
Masonic Medical Research Institute - MMRI
Masonic Medical Research Institute is a not-for-profit institute dedicated to improving the health and quality of life for all. The Laboratory's primary mission is to conduct high quality basic and clinical research aimed at generating knowledge and information necessary for development of medical cures and treatments of tomorrow. The Laboratory is also committed to providing education and training to basic scientists, clinical researchers and students who will perpetuate and extend the fight against disease.